Request for Covid-19 Impact Assessment of this Report
The United States Pediatric Influenza Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Influenza Treatment market, reaching US$ million by the year 2028. As for the Europe Pediatric Influenza Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pediatric Influenza Treatment players cover F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., and NESHER PHARMS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Influenza Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antiviral Drug
Antipyretic
Neuraminidase inhibitor
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc.
NATCO Pharma Limited.
NESHER PHARMS
Johnson & Johnsons Inc.
Cipla
Hetero Pharma
Teva Pharmaceutical pvt. Ltd.
Olainfarm JSC
Gilead Sciences, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediatric Influenza Treatment Market Size 2017-2028
2.1.2 Pediatric Influenza Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pediatric Influenza Treatment Segment by Type
2.2.1 Antiviral Drug
2.2.2 Antipyretic
2.2.3 Neuraminidase inhibitor
2.2.4 Others
2.3 Pediatric Influenza Treatment Market Size by Type
2.3.1 Pediatric Influenza Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
2.4 Pediatric Influenza Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Pediatric Influenza Treatment Market Size by Application
2.5.1 Pediatric Influenza Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
3 Pediatric Influenza Treatment Market Size by Player
3.1 Pediatric Influenza Treatment Market Size Market Share by Players
3.1.1 Global Pediatric Influenza Treatment Revenue by Players (2020-2022)
3.1.2 Global Pediatric Influenza Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Pediatric Influenza Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pediatric Influenza Treatment by Regions
4.1 Pediatric Influenza Treatment Market Size by Regions (2017-2022)
4.2 Americas Pediatric Influenza Treatment Market Size Growth (2017-2022)
4.3 APAC Pediatric Influenza Treatment Market Size Growth (2017-2022)
4.4 Europe Pediatric Influenza Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Pediatric Influenza Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pediatric Influenza Treatment Market Size by Country (2017-2022)
5.2 Americas Pediatric Influenza Treatment Market Size by Type (2017-2022)
5.3 Americas Pediatric Influenza Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Influenza Treatment Market Size by Region (2017-2022)
6.2 APAC Pediatric Influenza Treatment Market Size by Type (2017-2022)
6.3 APAC Pediatric Influenza Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pediatric Influenza Treatment by Country (2017-2022)
7.2 Europe Pediatric Influenza Treatment Market Size by Type (2017-2022)
7.3 Europe Pediatric Influenza Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Influenza Treatment by Region (2017-2022)
8.2 Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pediatric Influenza Treatment Market Forecast
10.1 Global Pediatric Influenza Treatment Forecast by Regions (2023-2028)
10.1.1 Global Pediatric Influenza Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Pediatric Influenza Treatment Forecast
10.1.3 APAC Pediatric Influenza Treatment Forecast
10.1.4 Europe Pediatric Influenza Treatment Forecast
10.1.5 Middle East & Africa Pediatric Influenza Treatment Forecast
10.2 Americas Pediatric Influenza Treatment Forecast by Country (2023-2028)
10.2.1 United States Pediatric Influenza Treatment Market Forecast
10.2.2 Canada Pediatric Influenza Treatment Market Forecast
10.2.3 Mexico Pediatric Influenza Treatment Market Forecast
10.2.4 Brazil Pediatric Influenza Treatment Market Forecast
10.3 APAC Pediatric Influenza Treatment Forecast by Region (2023-2028)
10.3.1 China Pediatric Influenza Treatment Market Forecast
10.3.2 Japan Pediatric Influenza Treatment Market Forecast
10.3.3 Korea Pediatric Influenza Treatment Market Forecast
10.3.4 Southeast Asia Pediatric Influenza Treatment Market Forecast
10.3.5 India Pediatric Influenza Treatment Market Forecast
10.3.6 Australia Pediatric Influenza Treatment Market Forecast
10.4 Europe Pediatric Influenza Treatment Forecast by Country (2023-2028)
10.4.1 Germany Pediatric Influenza Treatment Market Forecast
10.4.2 France Pediatric Influenza Treatment Market Forecast
10.4.3 UK Pediatric Influenza Treatment Market Forecast
10.4.4 Italy Pediatric Influenza Treatment Market Forecast
10.4.5 Russia Pediatric Influenza Treatment Market Forecast
10.5 Middle East & Africa Pediatric Influenza Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Pediatric Influenza Treatment Market Forecast
10.5.2 South Africa Pediatric Influenza Treatment Market Forecast
10.5.3 Israel Pediatric Influenza Treatment Market Forecast
10.5.4 Turkey Pediatric Influenza Treatment Market Forecast
10.5.5 GCC Countries Pediatric Influenza Treatment Market Forecast
10.6 Global Pediatric Influenza Treatment Forecast by Type (2023-2028)
10.7 Global Pediatric Influenza Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Information
11.1.2 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product Offered
11.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.1.5 F. Hoffmann-La Roche Ltd Latest Developments
11.2 GlaxoSmithKline Plc.
11.2.1 GlaxoSmithKline Plc. Company Information
11.2.2 GlaxoSmithKline Plc. Pediatric Influenza Treatment Product Offered
11.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GlaxoSmithKline Plc. Main Business Overview
11.2.5 GlaxoSmithKline Plc. Latest Developments
11.3 NATCO Pharma Limited.
11.3.1 NATCO Pharma Limited. Company Information
11.3.2 NATCO Pharma Limited. Pediatric Influenza Treatment Product Offered
11.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 NATCO Pharma Limited. Main Business Overview
11.3.5 NATCO Pharma Limited. Latest Developments
11.4 NESHER PHARMS
11.4.1 NESHER PHARMS Company Information
11.4.2 NESHER PHARMS Pediatric Influenza Treatment Product Offered
11.4.3 NESHER PHARMS Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 NESHER PHARMS Main Business Overview
11.4.5 NESHER PHARMS Latest Developments
11.5 Johnson & Johnsons Inc.
11.5.1 Johnson & Johnsons Inc. Company Information
11.5.2 Johnson & Johnsons Inc. Pediatric Influenza Treatment Product Offered
11.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnsons Inc. Main Business Overview
11.5.5 Johnson & Johnsons Inc. Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Pediatric Influenza Treatment Product Offered
11.6.3 Cipla Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Information
11.7.2 Hetero Pharma Pediatric Influenza Treatment Product Offered
11.7.3 Hetero Pharma Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Hetero Pharma Main Business Overview
11.7.5 Hetero Pharma Latest Developments
11.8 Teva Pharmaceutical pvt. Ltd.
11.8.1 Teva Pharmaceutical pvt. Ltd. Company Information
11.8.2 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product Offered
11.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Pharmaceutical pvt. Ltd. Main Business Overview
11.8.5 Teva Pharmaceutical pvt. Ltd. Latest Developments
11.9 Olainfarm JSC
11.9.1 Olainfarm JSC Company Information
11.9.2 Olainfarm JSC Pediatric Influenza Treatment Product Offered
11.9.3 Olainfarm JSC Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Olainfarm JSC Main Business Overview
11.9.5 Olainfarm JSC Latest Developments
11.10 Gilead Sciences, Inc.
11.10.1 Gilead Sciences, Inc. Company Information
11.10.2 Gilead Sciences, Inc. Pediatric Influenza Treatment Product Offered
11.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Gilead Sciences, Inc. Main Business Overview
11.10.5 Gilead Sciences, Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Pediatric Influenza Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antiviral Drug
Table 3. Major Players of Antipyretic
Table 4. Major Players of Neuraminidase inhibitor
Table 5. Major Players of Others
Table 6. Pediatric Influenza Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Pediatric Influenza Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
Table 9. Pediatric Influenza Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Pediatric Influenza Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
Table 12. Global Pediatric Influenza Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Pediatric Influenza Treatment Revenue Market Share by Player (2020-2022)
Table 14. Pediatric Influenza Treatment Key Players Head office and Products Offered
Table 15. Pediatric Influenza Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pediatric Influenza Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Pediatric Influenza Treatment Market Size Market Share by Regions (2017-2022)
Table 20. Americas Pediatric Influenza Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Pediatric Influenza Treatment Market Size Market Share by Country (2017-2022)
Table 22. Americas Pediatric Influenza Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
Table 24. Americas Pediatric Influenza Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
Table 26. APAC Pediatric Influenza Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Pediatric Influenza Treatment Market Size Market Share by Region (2017-2022)
Table 28. APAC Pediatric Influenza Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
Table 30. APAC Pediatric Influenza Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
Table 32. Europe Pediatric Influenza Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Pediatric Influenza Treatment Market Size Market Share by Country (2017-2022)
Table 34. Europe Pediatric Influenza Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
Table 36. Europe Pediatric Influenza Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Pediatric Influenza Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Pediatric Influenza Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Pediatric Influenza Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Pediatric Influenza Treatment
Table 45. Key Market Challenges & Risks of Pediatric Influenza Treatment
Table 46. Key Industry Trends of Pediatric Influenza Treatment
Table 47. Global Pediatric Influenza Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Pediatric Influenza Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Pediatric Influenza Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Pediatric Influenza Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Pediatric Influenza Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Pediatric Influenza Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 53. F. Hoffmann-La Roche Ltd Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 54. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product Offered
Table 55. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. F. Hoffmann-La Roche Ltd Main Business
Table 57. F. Hoffmann-La Roche Ltd Latest Developments
Table 58. GlaxoSmithKline Plc. Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 59. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product Offered
Table 60. GlaxoSmithKline Plc. Main Business
Table 61. GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. GlaxoSmithKline Plc. Latest Developments
Table 63. NATCO Pharma Limited. Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 64. NATCO Pharma Limited. Pediatric Influenza Treatment Product Offered
Table 65. NATCO Pharma Limited. Main Business
Table 66. NATCO Pharma Limited. Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. NATCO Pharma Limited. Latest Developments
Table 68. NESHER PHARMS Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 69. NESHER PHARMS Pediatric Influenza Treatment Product Offered
Table 70. NESHER PHARMS Main Business
Table 71. NESHER PHARMS Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. NESHER PHARMS Latest Developments
Table 73. Johnson & Johnsons Inc. Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 74. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product Offered
Table 75. Johnson & Johnsons Inc. Main Business
Table 76. Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Johnson & Johnsons Inc. Latest Developments
Table 78. Cipla Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 79. Cipla Pediatric Influenza Treatment Product Offered
Table 80. Cipla Main Business
Table 81. Cipla Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Cipla Latest Developments
Table 83. Hetero Pharma Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 84. Hetero Pharma Pediatric Influenza Treatment Product Offered
Table 85. Hetero Pharma Main Business
Table 86. Hetero Pharma Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Hetero Pharma Latest Developments
Table 88. Teva Pharmaceutical pvt. Ltd. Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 89. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product Offered
Table 90. Teva Pharmaceutical pvt. Ltd. Main Business
Table 91. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Teva Pharmaceutical pvt. Ltd. Latest Developments
Table 93. Olainfarm JSC Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 94. Olainfarm JSC Pediatric Influenza Treatment Product Offered
Table 95. Olainfarm JSC Main Business
Table 96. Olainfarm JSC Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Olainfarm JSC Latest Developments
Table 98. Gilead Sciences, Inc. Details, Company Type, Pediatric Influenza Treatment Area Served and Its Competitors
Table 99. Gilead Sciences, Inc. Pediatric Influenza Treatment Product Offered
Table 100. Gilead Sciences, Inc. Main Business
Table 101. Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Gilead Sciences, Inc. Latest Developments
List of Figures
Figure 1. Pediatric Influenza Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pediatric Influenza Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pediatric Influenza Treatment Market Size Market Share by Type in 2021
Figure 7. Pediatric Influenza Treatment in Hospitals
Figure 8. Global Pediatric Influenza Treatment Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Pediatric Influenza Treatment in Clinics
Figure 10. Global Pediatric Influenza Treatment Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Pediatric Influenza Treatment in Ambulatory Surgical Centers
Figure 12. Global Pediatric Influenza Treatment Market: Ambulatory Surgical Centers (2017-2022) & ($ Millions)
Figure 13. Pediatric Influenza Treatment in Others
Figure 14. Global Pediatric Influenza Treatment Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Pediatric Influenza Treatment Market Size Market Share by Application in 2021
Figure 16. Global Pediatric Influenza Treatment Revenue Market Share by Player in 2021
Figure 17. Global Pediatric Influenza Treatment Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Pediatric Influenza Treatment Market Size 2017-2022 ($ Millions)
Figure 19. APAC Pediatric Influenza Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Europe Pediatric Influenza Treatment Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Pediatric Influenza Treatment Market Size 2017-2022 ($ Millions)
Figure 22. Americas Pediatric Influenza Treatment Value Market Share by Country in 2021
Figure 23. Americas Pediatric Influenza Treatment Consumption Market Share by Type in 2021
Figure 24. Americas Pediatric Influenza Treatment Market Size Market Share by Application in 2021
Figure 25. United States Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Pediatric Influenza Treatment Market Size Market Share by Region in 2021
Figure 30. APAC Pediatric Influenza Treatment Market Size Market Share by Application in 2021
Figure 31. China Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Pediatric Influenza Treatment Market Size Market Share by Country in 2021
Figure 38. Europe Pediatric Influenza Treatment Market Size Market Share by Type in 2021
Figure 39. Europe Pediatric Influenza Treatment Market Size Market Share by Application in 2021
Figure 40. Germany Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Pediatric Influenza Treatment Market Size Market Share by Application in 2021
Figure 48. Egypt Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Pediatric Influenza Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 54. APAC Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 55. Europe Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 57. United States Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Canada Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 61. China Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Japan Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 63. Korea Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 65. India Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Australia Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 67. Germany Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 68. France Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 69. UK Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Italy Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Russia Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Spain Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 75. Israel Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Pediatric Influenza Treatment Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...